SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SSgA Active Trust - SPDR S&P 500 ETF Trust

SPY is experiencing significant volatility driven by President Trump's recent actions regarding Greenland and subsequent threats of substantial tariffs against European nations. The market community is sharply divided, with many bears predicting a major downturn, while bulls are actively preparing to "buy the dip" amidst broader uncertainty over global trade relations and geopolitical stability.

RAGE GUY (RAGE) is a cryptocurrency inspired by the Rage Guy meme, one of the earliest and most recognizable characters from internet rage comics. The project captures the cultural legacy of early meme history and brings it onto the blockchain in tokenized form. It is designed as a community-driven digital asset that celebrates internet culture, nostalgia, and the role memes play in shaping online communities.

Rage Guy

RAGE CRYPTO is trending as its highly engaged community champions the "OG meme" narrative of Rage Comics, positioning it as a "foundational meme reset" for the current market cycle. This dedicated base actively builds an ecosystem with platforms like RageMaker and RageGames, expressing strong conviction and urging fellow enthusiasts to "Return to the Memes" and "Rage On" to reclaim leadership in the meme coin space.

Bitcoin is the world's first decentralized cryptocurrency, created in 2009 by the pseudonymous Satoshi Nakamoto. It enables peer-to-peer electronic cash transactions without intermediaries like banks or governments, operating on a blockchain secured by Proof of Work mining and the SHA-256 cryptographic algorithm.   With a fixed supply cap of 21 million coins and programmatic halvings every four years that reduce miner rewards, Bitcoin is designed as a deflationary digital asset often called "digital gold." Its value stems from solving the double-spending problem without trusted intermediaries, creating the first truly scarce digital asset with censorship resistance and permissionless access that no government, corporation, or individual can control.  Bitcoin operates as a decentralized peer-to-peer network where transactions are recorded on a public ledger called the blockchain, distributed across thousands of computers globally. Transactions are grouped into blocks added approximately every 10 minutes through mining, where specialized computers compete to solve complex mathematical puzzles.   Bitcoin has achieved mainstream adoption through multiple vectors. The January 2024 SEC approval of 11 spot Bitcoin ETFs opened Bitcoin investment to traditional finance participants, and corporations like Strategy (formerly MicroStrategy) are using Bitcoin as a treasury reserve asset to protect against currency debasement, offering MSTR holders amplified exposure to Bitcoin.   The Bitcoin ecosystem continues to evolve with innovations like Ordinals, which emerged in January 2023 to enable NFT-like functionality directly on Bitcoin, and BRC-20 tokens, an experimental standard for creating fungible tokens using Ordinal inscriptions. BTCFi (Bitcoin Finance) represents emerging financial applications extending beyond Bitcoin's traditional role, with protocols like Babylon allowing Bitcoin holders to stake BTC to secure Proof of Stake chains.

Bitcoin

Bitcoin is trending due to rising geopolitical tensions between the U.S. and Europe, sparked by discussions around potential tariffs related to Greenland, with many attributing the recent market dip to these political actions. The community remains divided, with some anticipating further declines amid broad selling pressure, while others view the current pullback as a buying opportunity, especially with the Digital Asset Market Clarity Act markup scheduled.

Tesla, Inc. engages in the design, development, manufacture, and sale of electric vehicles and energy generation and storage systems. It operates through the Automotive and Energy Generation and Storage segments. The Automotive segment includes the design, development, manufacture, sale, and lease of electric vehicles as well as sales of automotive regulatory credits. The Energy Generation and Storage segment is involved in the design, manufacture, installation, sale, and lease of solar energy generation, energy storage products, and related services and sales of solar energy systems incentives. The company was founded by Jeffrey B. Straubel, Elon Reeve Musk, Martin Eberhard, and Marc Tarpenning on July 1, 2003 and is headquartered in Austin, TX.

Tesla Inc

Tesla is trending as Elon Musk announces rapid advancements in AI chip development (AI5, AI6) and plans for a "TeraFab" to boost production, sparking widespread community debate. This ambitious AI push is met with bullish excitement for future robotaxi and robotics potential, while skeptics point to reported softness in global vehicle sales across various regions and intensifying competition. The upcoming earnings report serves as a key point of focus for investors evaluating these contrasting narratives.

Invesco Capital Management LLC - Invesco QQQ Trust Series 1

QQQ is trending as renewed geopolitical tensions stemming from discussions around Greenland and potential tariffs from former President Trump on European goods spark significant market conversation. The community is split between fears of a deeper market pullback and those anticipating a swift "buy the dip" recovery, driven by the index's historical resilience amidst political volatility and upcoming tech earnings.

Venus Concept, Inc. is a global medical technology company, which engages in the business of developing, commercializing, and selling minimally invasive and non-invasive medical aesthetic and hair restoration technologies. It operates under the United States and International geographical segments. The company was founded on November 22, 2002 and is headquartered in Toronto, Canada.

Venus Concept Inc

Venus Concept (VERO) is trending amid intense debate following Madryn Asset Management's reported 91% ownership stake. Bulls are aggressively pushing the narrative that this unprecedented "float lock" will lead to astronomical gains by neutralizing short-selling pressure. However, a strong contingent of skeptics warns of weak company fundamentals and suggests the large stake could ultimately lead to privatization or delisting, casting the recent surge as an unsustainable pump-and-dump.

Critical Metals Corp. engages in the mining, exploration, and development of lithium metals. It owns Wolfsberg Project and Tanbreez Project. The company was founded on October 24, 2022 and is headquartered in British Virgin Islands.

Critical Metals Corp.

Critical Metals Corp. is trending due to heightened geopolitical interest surrounding Greenland's critical mineral resources, driven by former President Trump's strong advocacy for US acquisition or strategic involvement. The community is actively discussing the potential for a transformative deal that would secure vital rare earth supplies, alongside the company's recent joint venture for processing. This strategic exposure is generating significant market buzz, with many anticipating substantial future gains ahead of its upcoming business update call.

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+ and TMTG News. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

Trump Media & Technology Group is trending as discussions erupt over former President Trump's recent stance on Greenland, including potential tariffs on European nations and perceived links to the Nobel Peace Prize. The community is sharply divided, with some expressing concern over escalating geopolitical tensions and market uncertainty, while others laud the assertive "America First" strategy. These developments are amplifying debates on global trade relations and international alliances.

SPDR Gold Trust - SPDR Gold Shares

SPDR Gold Shares ETF

GLD is experiencing a significant surge to new all-time highs, propelled by escalating geopolitical tensions, including recent tariff threats against Europe and broader global instability. The community is actively discussing whether this rally reflects a critical flight to safety amidst concerns over the US dollar's strength and eroding confidence in fiat currencies, with many anticipating sustained upward momentum for precious metals.

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

ImmunityBio is experiencing intense buzz driven by recent Saudi FDA approval for its Anktiva cancer treatment, particularly for non-small cell lung cancer, along with positive clinical trial results. The community is highly optimistic about the company's "no chemo/radiation" approach and the potential for a massive short squeeze, with Dr. Patrick Soon-Shiong's active engagement amplifying discussions around a paradigm shift in global cancer therapy.

statis crypto Watchlist

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Campbell & CO Investment Adviser LLC Invests $1.21 Million in Apellis Pharmaceuticals, Inc. $APLS

Campbell & CO Investment Adviser LLC purchased a new stake in shares of Apellis Pharmaceuticals, Inc. (NASDAQ:APLS - Free Report) during the third quarter, according to the company in its most recent...

Insider Selling: Apellis Pharmaceuticals (NASDAQ:APLS) CAO Sells $19,371.87 in Stock

Apellis Pharmaceuticals, Inc. (NASDAQ:APLS - Get Free Report) CAO James George Chopas sold 873 shares of the stock in a transaction dated Tuesday, January 13th. The stock was sold at an average price...

Apellis Pharmaceuticals (NASDAQ:APLS) Insider Pascal Deschatelets Sells 2,277 Shares

Apellis Pharmaceuticals, Inc. (NASDAQ:APLS - Get Free Report) insider Pascal Deschatelets sold 2,277 shares of the firm's stock in a transaction that occurred on Tuesday, January 13th. The stock was...

Mark Jeffrey Delong Sells 1,780 Shares of Apellis Pharmaceuticals (NASDAQ:APLS) Stock

Apellis Pharmaceuticals, Inc. (NASDAQ:APLS - Get Free Report) insider Mark Jeffrey Delong sold 1,780 shares of the stock in a transaction that occurred on Tuesday, January 13th. The stock was sold at...

Insider Selling: Apellis Pharmaceuticals (NASDAQ:APLS) Insider Sells 2,618 Shares of Stock

Apellis Pharmaceuticals, Inc. (NASDAQ:APLS - Get Free Report) insider Nur Nicholson sold 2,618 shares of the firm's stock in a transaction dated Tuesday, January 13th. The stock was sold at an...

Insider Selling: Apellis Pharmaceuticals (NASDAQ:APLS) CFO Sells 3,856 Shares of Stock

Apellis Pharmaceuticals, Inc. (NASDAQ:APLS - Get Free Report) CFO Timothy Eugene Sullivan sold 3,856 shares of the stock in a transaction on Tuesday, January 13th. The stock was sold at an average...

David Watson Sells 5,780 Shares of Apellis Pharmaceuticals (NASDAQ:APLS) Stock

Apellis Pharmaceuticals, Inc. (NASDAQ:APLS - Get Free Report) General Counsel David Watson sold 5,780 shares of the business's stock in a transaction that occurred on Tuesday, January 13th. The stock...

Apellis Pharmaceuticals (NASDAQ:APLS) CEO Sells $226,027.34 in Stock

Apellis Pharmaceuticals, Inc. (NASDAQ:APLS - Get Free Report) CEO Cedric Francois sold 10,186 shares of the business's stock in a transaction dated Tuesday, January 13th. The stock was sold at an...

Apellis Stock Crashes 23% in a Week: Here's What You Should Know

APLS stock plunges 23% in a week after reporting $190 million in preliminary Q4 U.S. net product revenues, as weaker Syfovre sales and mixed Empaveli uptake disappoint investors.

Apellis Pharmaceuticals (NASDAQ:APLS) Stock Price Down 5.8% on Analyst Downgrade

Apellis Pharmaceuticals (NASDAQ:APLS) Shares Down 5.8% on Analyst Downgrade...

Apellis Pharmaceuticals, Inc. is a commercial-stage biopharmaceutical company, which engages in the discovery, development, and commercialization of novel therapeutic compounds to treat diseases with high unmet needs. Its products include EMPAVELI and SYFOVRE. The company was founded by Candace Rose Depp, Pascal Deschatelets, Cedric Francois, and Alec Machiels on September 25, 2009 and is headquartered in Waltham, MA.

Current Price	$19.94
Prev Close	$20.53
Open	$20.53
Dividend Yield	0.00%
50-Day Moving Average	$22.63
Beta	1.02
Avg. Volume	2.25M
PE Ratio	67.16

52-Week High	$31.17
52-Week Low	$16.10
Market Capitalization	$2.52B
EPS (Annual)	-$1.60
Price to Book	6.29
Revenue Per Employee	$1.1M
Enterprise Value/EBITDA	N/A

APLS
Apellis Pharmaceuticals Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest APLS News

APLSApellis Pharmaceuticals Inc